Company reports all-time-high monthly cartridge sales for July with 60% year-on-year growth
Company reports all-time-high monthly cartridge sales for July with 60% year-on-year growth
Related Questions
How will the 60% YoY increase in higher‑margin cartridge sales affect IBIO's upcoming earnings guidance and EPS forecasts?
Is the record cartridge volume sustainable, and what are the risks to maintaining this growth trajectory in the coming quarters?
How does IBIO's margin expansion from these cartridge sales compare to peers in the biotech consumables space, and what implications does that have for its valuation relative to the industry?